NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF

NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF

The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their product...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RINK RICK, NELEMANS SIEGER ADRIAAN, ROKS Antonius Jacobus Marinus, DE VRIES LOUWE, MOLL GERT NIKOLAAS
Format: Patent
Sprache:eng ; pol
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RINK RICK
NELEMANS SIEGER ADRIAAN
ROKS Antonius Jacobus Marinus
DE VRIES LOUWE
MOLL GERT NIKOLAAS
description The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2643342TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2643342TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2643342TT33</originalsourceid><addsrcrecordid>eNrjZHD08w9z9VFw9HP39A9x9Qv29FMIiQxwVTBS0HAMMdJUCHJ1dg0I8Q9ScHT39_MMDgkGKnVRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QE-RmYmxsYmRiEhxsbEqAEAr00q_Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><source>esp@cenet</source><creator>RINK RICK ; NELEMANS SIEGER ADRIAAN ; ROKS Antonius Jacobus Marinus ; DE VRIES LOUWE ; MOLL GERT NIKOLAAS</creator><creatorcontrib>RINK RICK ; NELEMANS SIEGER ADRIAAN ; ROKS Antonius Jacobus Marinus ; DE VRIES LOUWE ; MOLL GERT NIKOLAAS</creatorcontrib><description>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.</description><language>eng ; pol</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170929&amp;DB=EPODOC&amp;CC=PL&amp;NR=2643342T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170929&amp;DB=EPODOC&amp;CC=PL&amp;NR=2643342T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RINK RICK</creatorcontrib><creatorcontrib>NELEMANS SIEGER ADRIAAN</creatorcontrib><creatorcontrib>ROKS Antonius Jacobus Marinus</creatorcontrib><creatorcontrib>DE VRIES LOUWE</creatorcontrib><creatorcontrib>MOLL GERT NIKOLAAS</creatorcontrib><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><description>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD08w9z9VFw9HP39A9x9Qv29FMIiQxwVTBS0HAMMdJUCHJ1dg0I8Q9ScHT39_MMDgkGKnVRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QE-RmYmxsYmRiEhxsbEqAEAr00q_Q</recordid><startdate>20170929</startdate><enddate>20170929</enddate><creator>RINK RICK</creator><creator>NELEMANS SIEGER ADRIAAN</creator><creator>ROKS Antonius Jacobus Marinus</creator><creator>DE VRIES LOUWE</creator><creator>MOLL GERT NIKOLAAS</creator><scope>EVB</scope></search><sort><creationdate>20170929</creationdate><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><author>RINK RICK ; NELEMANS SIEGER ADRIAAN ; ROKS Antonius Jacobus Marinus ; DE VRIES LOUWE ; MOLL GERT NIKOLAAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2643342TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>RINK RICK</creatorcontrib><creatorcontrib>NELEMANS SIEGER ADRIAAN</creatorcontrib><creatorcontrib>ROKS Antonius Jacobus Marinus</creatorcontrib><creatorcontrib>DE VRIES LOUWE</creatorcontrib><creatorcontrib>MOLL GERT NIKOLAAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RINK RICK</au><au>NELEMANS SIEGER ADRIAAN</au><au>ROKS Antonius Jacobus Marinus</au><au>DE VRIES LOUWE</au><au>MOLL GERT NIKOLAAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><date>2017-09-29</date><risdate>2017</risdate><abstract>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL2643342TT3
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A08%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RINK%20RICK&rft.date=2017-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2643342TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true